Skip to content

Author

F. Mallamaci

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic Strategies.

Aldosterone, the terminal effector of the renin-angiotensin-aldosterone system, regulates sodium retention, potassium excretion, and blood pressure. Beyond these classical effects, aldosterone-associated and mineralocorticoid receptor (MR)-mediated signaling is implicated in inflammation, oxidative stress, fibrosis, al...

Mehmet Kanbay, Rama Al-Shiab, Ermeena Shah et al. · 0 citations
Review Open access Sep 2026

Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis.

BACKGROUND AND AIMS Sodium-glucose cotransporter-2 inhibitors (SGLT2is) improve cardiovascular and kidney outcomes, but their effects on circulating inflammatory biomarkers remain uncertain. We systematically reviewed randomized evidence on the effects of SGLT2is on peripheral-blood inflammatory biomarkers. METHODS P...

Mehmet Kanbay, Ermeena Shah, Rama Al-Shiab et al. · 0 citations
Review Sep 2026

Beyond Kt/V: Redefining Dialysis Adequacy as Targeted Cardiovascular Risk Reduction.

BACKGROUND Cardiovascular disease remains the leading cause of death in patients receiving maintenance dialysis, whereas conventional thrice-weekly hemodialysis was developed primarily around small-solute clearance rather than cardiovascular protection. AIM This narrative review examines dialysis strategies intended...

Carmine Zoccali, Giovanni F. M. Strippoli, Francesco Locatelli et al. · 0 citations
Review Aug 2026

Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping.

Patients with chronic kidney disease (CKD) bear a disproportionate burden of cardiovascular (CV) morbidity and mortality, yet preventive strategies in clinical practice remain remarkably conservative and largely therapy-centered. The 2024 KDIGO guideline on CKD evaluation and management advocates the systematic use of...

Carmine Zoccali, C. Kovesdy, F. Mallamaci et al. · 0 citations
Aug 2026

The nephrologist in the present and near future: between algorithms and autonomy.

Overall, AI can support proactive, person-centred kidney care only if clinicians help design, govern, evaluate, and critically supervise these emerging technologies within robust, learning healthcare systems.

Carmine Zoccali, F. Mallamaci · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.